Combined treatment eficacity of pre-myopes aged 6-10 years with familial factor
Închide
Articolul precedent
Articolul urmator
132 0
SM ISO690:2012
BÎLBA, Rodica, DUMBRĂVEANU, Lilia, CUSHNIR, V., CHIRIAC, Vera, CURCA, Stelian, COŞULA, Cristina, CECAN, Mihaela. Combined treatment eficacity of pre-myopes aged 6-10 years with familial factor. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 208. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

Combined treatment eficacity of pre-myopes aged 6-10 years with familial factor


Pag. 208-208

Bîlba Rodica, Dumbrăveanu Lilia, Cushnir V., Chiriac Vera, Curca Stelian, Coşula Cristina, Cecan Mihaela
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 26 decembrie 2023


Rezumat

Introduction. Myopia management is an exciting area with new research and technology advancements that will allow us to detect the pre-myope earlier and more accurately manage pre-myopia. Material and methods. Clinical retrospective study, that included 20 pre-myopes (40 eyes) aged 6-10 years with familial factor. The combined treatment (physiotherapy and antifatigue lenses-Rhein Vision’s Facile) was applied for 2 years. Results. In base group with familial factor, the spherical equivalent increased (from 0.59 to -0.23 D) after 2 years of treatment, and the vitreous chamber depth increased (from 15,60 to 15,79 mm). In the control group, aged 6-10 years with familial factor the spherical equivalent has increased (from +0,66 to -0.76 D) after 2 years of treatment. The vitreous chamber depth has changed (from 16,59 to 17,02 mm) after 2 years. Between the basic group and control group, it was determined the statistical difference (p>0.05). Conclusions. Significantly higher frequency of myopia onset was determined in the control group (21% of the combined treatament vs 74% of the control).